pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Type of fix-dose combination antihypertensives

Type of fix-dose combination antihypertensives

Combinations of only antihypertensives
Angiotensin converting enzyme inhibitor/calcium channel blocker (ACEI/CCB)
ramipril+felodipine

Angiotensin converting enzyme inhibitor/diuretic (ACEI/DU)
perindopril+indapamide

Angiotensin II receptor blocker/calcium channel blocker (ARB/CCB)
fimasartan+amlodipine losartan+amlodipine olmesartan+amlodipine
olmesartan+S-amlodipine telmisartan+amlodipine telmisartan+S-amlodipine
valsartan+amlodipine valsartan+lercanidipine valsartan+S-amlodipine

Angiotensin II receptor blocker/calcium channel blocker/diuretic (ARB/CCB/DU)
losartan+amlodipine+chlorthalidone olmesartan+amlodipine+HCTZ
telmisartan+amlodipine+chlorthalidone telmisartan+amlodipine+HCTZ

Angiotensin II receptor blocker/diuretic (ARB/DU)
azilsartan+chlorthalidone candesartan+HCTZ eprosartan+HCTZ
fimasartan+HCTZ irbesartan+HCTZ losartan+HCTZ
olmesartan+HCTZ telmisartan+HCTZ valsartan+HCTZ

Beta blocker/diuretic (BB/DU)
atenolol+chlorthalidone bisoprolol+HCTZ

Calcium channel blocker/beta blocker (CCB/BB)
felodipine+metoprolol

Diuretic/diuretic (DU/DU)
HCTZ+spironolactone

Combinations of antihypertensives and sacubitril or statins
Angiotensin II receptor blocker/sacubitril (ARB/SACU)
valsartan+sacubitril

Angiotensin II receptor blocker/calcium channel blocker/statin (ARB/CCB/S)
losartan+amlodipine+rosuvastatin losartan+amlodipine+rosuvastatin
telmisartan+amlodipine+rosuvastatin telmisartan+amlodipine+rosuvastatin

Angiotensin II receptor blocker/statin (ARB/S)
candesartan+rosuvastatin fimasartan+rosuvastatin irbesartan+atorvastatin
olmesartan+rosuvastatin S-amlodipine+atrovastatin telmisartan+rosuvastatin
valsartan+pitavastatin valsartan+rosuvastatin

Beta blocker/statin (BB/S)
nebivolol+rosuvastatin

Calcium channel blocker/statin (CCB/S)
amlodipine+atorvastatin amlodipine+rosuvastatin

HCTZ, hydrochlorothiazide

Korean J Clin Pharm 2022;32:125-32 https://doi.org/10.24304/kjcp.2022.32.2.125
© 2022 Korean J Clin Pharm